India Globalization Capital Inc. (IGC) News

India Globalization Capital Inc. (IGC): $0.36

0.00 (0.78%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

F

Add IGC to Watchlist
Sign Up

Industry: Industrial - Services

Industry

B

Ranked

#75 of 78

in industry

Filter IGC News Items

IGC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

IGC News Highlights

  • IGC's 30 day story count now stands at 3.
  • Over the past 13 days, the trend for IGC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about IGC are MD, DRUG and JPM.

Latest IGC News From Around the Web

Below are the latest news stories about IGC PHARMA INC that investors may wish to consider to help them evaluate IGC as an investment opportunity.

Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s

POTOMAC, Md., December 19, 2023--Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s

Yahoo | December 19, 2023

IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024

POTOMAC, Md., December 13, 2023--IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024

Yahoo | December 13, 2023

IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials

POTOMAC, Md., December 06, 2023--IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American: IGC) today announced an Artificial Intelligence (AI) collaboration with Los Andes University’s Center for Research and Training in Artificial Intelligence ("CINFONIA"). The partnership aims to leverage Generative AI (AI) to analyze variations in disease signatures among patients, enabling IGC Pharma to identify individuals more likely to respond to treatment and subsequently accelerate the delivery of trea

Yahoo | December 6, 2023

IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives

POTOMAC, Md., November 21, 2023--IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives

Yahoo | November 21, 2023

IGC Pharma Reports Second Quarter Fiscal 2024 Results

POTOMAC, Md., November 13, 2023--IGC Pharma Reports Second Quarter Fiscal 2024 Results.

Yahoo | November 13, 2023

IGC Pharma Granted European Patent for Groundbreaking Cannabinoid-Based Pain Topical Relief Therapy

POTOMAC, Md., October 19, 2023--IGC Pharma Granted European Patent for Groundbreaking Cannabinoid-Based Pain Topical Relief Therapy.

Yahoo | October 19, 2023

IGC Announces Results of its 2023 Annual Stockholders Meeting

POTOMAC, Md., August 21, 2023--IGC Announces Results of its 2023 Annual Stockholders Meeting

Yahoo | August 21, 2023

IGC Pharma Reports First Quarter Results; Company Continues to Make Significant Progress Advancing Its Lead Alzheimer’s Candidate Through Phase 2 Clinical Trials

POTOMAC, Md., August 14, 2023--IGC Pharma Reports First Quarter Results; Company Continues to Make Significant Progress Advancing Its Lead Alzheimer’s Candidate.

Yahoo | August 14, 2023

IGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the University of Puerto Rico

POTOMAC, Md., August 02, 2023--IGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the University of Puerto Rico

Yahoo | August 2, 2023

IGC Pharma, Inc. Presenting 6 Posters on the Positive Impact of IGC-AD1 on Neuropsychiatric Symptoms in Dementia at the 2023 Alzheimer’s Association International Conference

POTOMAC, Md., July 18, 2023--IGC 's 6 Posters on Positive Impact of IGC-AD1 on Neuropsychiatric Symptoms of Dementia at 2023 Alzheimer’s Association International Conference.

Yahoo | July 18, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!